SIGN UPLog In

Last deal

$66M

Amount

Series B

Stage

15.12.2023

Date

3

all rounds

$106M

Total amount

General

About Company
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.

Industry

Sector :

Subsector :

Also Known As

Totus, Trilogy Sciences

founded date

01.01.2020

Number of employees

11-50

Company Type

For Profit

Last funding type

Series B

IPO status

Private

Description

Totus Medicines uses revolutionary chemical biology to create life-changing therapies to treat previously untreatable diseases.
Contacts

location

Cambridge, MA, USA

Phone number

Website URL

https://www.totusmedicines.com/

Social url